| Name | Osco Pharmacy #4023 |
|---|---|
| Organization Name | Albertsons Llc |
| Location | 307 Harmon St, Glendive, Montana 59330 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (406) 365-5209 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 25th annual conference in San Diego. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that two oral podium presentations on the company's lead candidate, PRX302, will be made at the 2010 Annual Meeting of the American Urological Association (AUA). These presentations will include six month data from the Phase 2b clinical study of PRX302 called TRIUMPH, in patients with moderate to severe benign prostatic hyperplasia (BPH).
Electrical stimulation on the skin surface at the elbow can produce feeling in the hand—including rare "natural" sensations—according to a study just published in the Journal of Rehabilitation Research and Development.
Neonatal withdrawal signs have been documented in newborns of mothers treated with antidepressants and are known as a cause of neonatal morbidity.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
› Verified 5 days ago
| NPI Number | 1346296266 |
| Organization Name | ALBERTSONS LLC |
| Doing Business As | OSCO PHARMACY #4023 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 307 Harmon St, Glendive, MT 59330 |
| Phone Number | 406-365-5209 |
News Archive
The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 25th annual conference in San Diego. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that two oral podium presentations on the company's lead candidate, PRX302, will be made at the 2010 Annual Meeting of the American Urological Association (AUA). These presentations will include six month data from the Phase 2b clinical study of PRX302 called TRIUMPH, in patients with moderate to severe benign prostatic hyperplasia (BPH).
Electrical stimulation on the skin surface at the elbow can produce feeling in the hand—including rare "natural" sensations—according to a study just published in the Journal of Rehabilitation Research and Development.
Neonatal withdrawal signs have been documented in newborns of mothers treated with antidepressants and are known as a cause of neonatal morbidity.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
› Verified 5 days ago
News Archive
The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 25th annual conference in San Diego. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that two oral podium presentations on the company's lead candidate, PRX302, will be made at the 2010 Annual Meeting of the American Urological Association (AUA). These presentations will include six month data from the Phase 2b clinical study of PRX302 called TRIUMPH, in patients with moderate to severe benign prostatic hyperplasia (BPH).
Electrical stimulation on the skin surface at the elbow can produce feeling in the hand—including rare "natural" sensations—according to a study just published in the Journal of Rehabilitation Research and Development.
Neonatal withdrawal signs have been documented in newborns of mothers treated with antidepressants and are known as a cause of neonatal morbidity.
Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.
› Verified 5 days ago
Osco Pharmacy #4023 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 307 Harmon St, Glendive, Montana 59330 Phone: (406) 365-5209 | |
Glendive Eye Care Type: Medicare Supplier Location: 115 W Valentine St, Glendive, Montana 59330 Phone: (406) 365-8231 |